Sernova Biotherapeutics Inc
SEOVF
$0.1219
$0.00141.16%
OTC PK
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.81M | -20.48M | -23.69M | -28.67M | -30.61M |
| Total Depreciation and Amortization | 310.70K | 353.00K | 396.70K | 360.50K | 323.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.05M | 1.14M | 1.18M | 2.09M | 2.49M |
| Change in Net Operating Assets | 2.93M | 4.84M | 8.21M | 6.83M | 7.60M |
| Cash from Operations | -11.52M | -14.15M | -13.90M | -19.39M | -20.19M |
| Capital Expenditure | -- | -- | -- | 0.00 | -7.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.68M | 6.63M | 8.17M | 9.77M | 13.30M |
| Cash from Investing | 3.68M | 6.63M | 8.17M | 9.77M | 13.30M |
| Total Debt Issued | 4.67M | -- | -- | -- | -- |
| Total Debt Repaid | -169.80K | -168.50K | -169.10K | -170.50K | -171.30K |
| Issuance of Common Stock | 5.21M | 5.23M | 5.23M | 15.80K | 15.80K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -120.30K | 72.70K | 7.90K | 423.70K | 355.30K |
| Cash from Financing | 6.89M | 3.76M | 3.71M | 197.60K | 146.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -942.90K | -3.76M | -2.02M | -9.42M | -6.75M |